Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers September 24, 2017
Pharmacy Choice - Pharmaceutical News - Vanderbilt University and Bayer to evaluate new drug candidates for kidney diseases [T-break Tech (Middle East)] - September 24, 2017

Pharmacy News Article

 9/13/17 - Vanderbilt University and Bayer to evaluate new drug candidates for kidney diseases [T-break Tech (Middle East)]

Vanderbilt University Medical Center (VUMC) and Bayer are set to form a strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.

The five-year drug discovery project is aimed at accelerating the translation of new approaches from the laboratory to pre-clinical development.

Furthermore, the goal is to develop two new investigational drugs addressing the medical need of end-stage renal disease (ESRD) within the time frame of the alliance.

VUMC nephrology division director Raymond Harris said: We are excited about this partnership with Bayer to develop new drugs and novel therapies to target patients who have kidney diseases and to stop their progression.

At least 30 million people in the US have kidney disease, and it is greater in the African-American, Hispanic, Native American and Pacific Islander populations.

"We are excited about this partnership with Bayer to develop new drugs and novel therapies to target patients who have kidney diseases and to stop their progression."

We have a severe shortage and limited number of kidneys available through living and cadaver donors. We dont have enough options. The best thing would be to never have to go on dialysis.

Under the agreement, VUMC and Bayer will jointly conduct research activities such as target validation, assay development and lead optimisation.

The companies will also contribute personnel and infrastructure in a bid to address important scientific questions.

Through the project, Vanderbilt will work on various other projects to develop a range of potential compounds that will be tested and used on patients.

Working alongside the universitys institute for chemical biology, the division of nephrology will soon prepare a treatment for clinical trial testing.



(c) 2017 TBREAK MEDIA. ALL RIGHTS RESERVED. Provided by SyndiGate Media Inc. (Syndigate.info).

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Last Chance
Sep 25: Management of Major Depressive Disorders
Sep 26: Vitamins, Minerals, and Electrolytes in Older Adults
Sep 27: Medication Use During Pregnancy & Lactation
Sep 28: An Integrative Approach to Managing Arthritis
Sep 29: Legal & Practical Issues in Compounding Pharmacy
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415